Brief: Novartis India Approves Termination Of Distribution Agreement With Dr. Reddy's Laboratories
BRIEF-Novartis India Approves Termination Of Distribution Agreement With Dr. Reddy's Laboratories Aug 7 (Reuters) - Novartis India Ltd NOIN.BO:
NOVARTIS INDIA - APPROVES TERMINATION OF DISTRIBUTION AGREEMENT WITH DR. REDDY’S LABORATORIES
NOVARTIS INDIA - TERMINATION AGREEMENT WITH DR. REDDY’S EFFECTIVE SEPTEMBER 30, 2026
NOVARTIS INDIA - TO RE-BUY EXCLUSIVITY AND MARKET ACCESS FOR PRODUCTS AFTER DRL AGREEMENT TERMINATION
Source text: ID:nBSE9P3wlf
Further company coverage: NOIN.BO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Dr. Reddy's Laboratories
See all newsDr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit
Dr Reddy's beats quarterly profit estimate on India market lift (updated)
India's Dr Reddy's beats quarterly profit estimate
Brief: Dr. Reddy's Q2 Consol Net PAT 9.25 Billion Rupees
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption